Unite our hearts and minds to build an ideal together
To enhance team cohesion and enrich employees' cultural life, our company organized a team-building event on May 17, 2026.
Nimesulide tablets—Approved for Marketing
On April 21, 2026, our company's nimusulide tablets were approved for market launch.
Betastine Hydrochloride Tablets—Approved for Marketing
On April 7, 2026, our company's betahistine dihydrochloride tablets were approved for market launch under the new chemical drug registration category
Haloperidol tablets - Approved for Marketing
On December 17, 2025, our company's fluphenazine tablets were approved for market release.
Haloperidol Injection - Approved for Marketing
On October 21, 2025, our company's haloperidol injection was approved for market release.
Lacosamide tablets - third-generation antiepileptic drugs
This product has been approved under the new registration category for chemical drugs, and is regarded as having passed the consistency assessment.